DLHCX Mutual Fund

DLHCX Mutual Fund

NAV$23.31
See how much of DLHCX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 50 of 108 holdings · as of Jul 31, 2026
DLHCX holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
REGN
Regeneron Pharmaceuticals, Inc.Health Care · Pharmaceuticals
4.82%		4.8%47,000$35.84MHealth CarePharmaceuticals
2—Ucb SaHealth Care · Pharmaceuticals
4.49%		9.3%130,137$33.40MHealth CarePharmaceuticals
Sector and industry · Pro
3
ABBV
AbbVie Inc.
4.22%		13.5%125,000$31.37M
4
PFE
Pfizer Inc
4.06%		17.6%1,207,000$30.19M
5
LLY
Eli Lilly & Co.
4.02%		21.6%26,000$29.87M
6
UNH
Unitedhealth Group Inc
3.90%		25.5%70,000$29.01M
7
MRK
Merck & Company Inc
3.76%		29.3%215,000$27.99M
8
GILD
Gilead Sciences
3.68%		32.9%210,000$27.34M
9—Roche Ps Par Ag
3.23%		36.2%55,000$24.04M
10
ELV
Elevance Health Inc
3.18%		39.4%63,000$23.68M
11—AstraZeneca PLC
3.00%		42.4%131,243$22.33M
12
VTRS
Viatris Inc.
2.76%		45.1%1,170,018$20.55M
13—Chugai Pharmaceutical Co. Ltd. Com Stk
2.63%		47.7%450,000$19.53M
14
ILMN
Illumina, Inc.
2.48%		50.2%90,000$18.46M
15
ORKA
Oruka Therapeutics Inc Orka
2.47%		52.7%190,000$18.34M
16
HALO
Halozyme Therapeutics Inc
2.44%		55.1%220,000$18.16M
17
AMGN
Amgen Inc.
2.43%		57.6%47,000$18.10M
18—Alkermes Plc. Ordinary Shares
1.71%		59.3%260,000$12.74M
19
ZBH
Zimmer Biomet Holdings
1.63%		60.9%128,700$12.09M
20—Nvaesrtex Pharmaceuticals Inc
1.60%		62.5%25,000$11.93M
21
BSX
Boston Scientific Corp.
1.57%		64.1%250,000$11.68M
22
NBIX
Neurocrine Biosciences Inc
1.57%		65.6%70,000$11.68M
23—Roivant Sciences Ltd. Common Shares
1.54%		67.2%338,181$11.47M
24
RCUS
Arcus Biosciences Inc
1.44%		68.6%379,100$10.69M
25
MDT
Medtronic plc
1.44%		70.1%125,000$10.67M
26
VKTX
Viking Therapeutics Inc
1.41%		71.5%330,100$10.48M
27
SNY
Sanofi SA
1.39%		72.9%120,000$10.33M
28—Stryker Corp 3.375 11/25
1.34%		74.2%30,500$9.93M
29
INCY
Incyte Corp.
1.29%		75.5%80,000$9.56M
30
ABT
Abbott Laboratories
1.28%		76.8%90,000$9.51M
31—Uniqure N.V. Ordinary Shares
1.28%		78.1%217,500$9.49M
32
COGT
Cogent Biosciences Inc
1.20%		79.3%230,000$8.95M
33
CVS
Cvs Health Corp.
1.05%		80.3%75,000$7.83M
34
FNMA
Federal National Mortgage Association
1.01%		81.3%1,300,000$7.53M
35
DGX
Quest Diagnostics Inc
0.94%		82.3%30,000$6.99M
36
ALNY
Alnylam Pharmaceuticals Inc.
0.83%		83.1%30,000$6.17M
37
BMRN
Biomarin Pharmaceutical Inc.
0.81%		83.9%100,000$6.00M
38
RIGL
Rigel Pharmaceuticals Inc
0.79%		84.7%160,000$5.89M
39
FMCC
Freddie Mac Preferred Stock
0.78%		85.5%1,050,000$5.78M
40
GRAL
Grail, Inc.
0.78%		86.3%85,000$5.83M
41
BIIB
Biogen Inc.
0.76%		87.0%28,000$5.68M
42
JNJ
Johnson & Johnson -
0.69%		87.7%20,000$5.13M
43
ANAB
Anaptysbio Inc
0.67%		88.4%93,732$5.00M
44
IMVT
Immunovant Inc
0.63%		89.0%122,100$4.72M
45
TARS
Tarsus Pharmaceuticals Inc
0.63%		89.6%79,172$4.67M
46
VIR
Vir Biotechnology Inc.
0.58%		90.2%500,000$4.33M
47
TRAX
First Tracks Biotherapeutics, Inc.
0.56%		90.8%93,732$4.13M
48
XNCR
Xencor Inc
0.54%		91.3%200,000$4.04M
49—Abivax Sa Sponsored Adr (1 Ads : 1 Ordinary)
0.50%		91.8%30,000$3.75M
50
TBPH
Theravance Biopharma Inc
0.47%		92.3%208,783$3.52M
More holdings · Pro
Not reported for this fund: share changes.
FundXLS Pro
See the other 58 holdings of DLHCX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

DLHCX Mutual Fund All Holdings

DLHCX holdings total 106 positions. The top 10 holdings account for 39.4% of the fund, led by Regeneron Pharmaceuticals, Inc. at 4.8%, Ucb Sa at 4.5%, Abbvie Inc. at 4.2%.

DLHCX portfolio concentration is moderate, with the top 10 representing 39.4% of total assets. The largest sector exposure is Health Care at 78.4%.

DLHCX sectors provide a detailed breakdown. DLHCX overlap shows how holdings compare to other funds in your portfolio.